| 6643 |
Strategy of Anti-Platelet Therapy After PCI in High-Risk Patients |
Youngwoo Jang |
Apr. 17. 25 |
| 6642 |
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease |
Do-Yoon Kang |
Apr. 17. 25 |
| 6641 |
Strategic Long-Term Use of Clopidogrel in Acute Coronary Syndrome |
Si-Hyuck Kang |
Apr. 17. 25 |
| 6640 |
Strategic Acute Phase ACS Management: Clopidogrel-Centric Approaches |
Sanghoon Shin |
Apr. 17. 25 |
| 6639 |
How Do We Achieve Lower for Longer LDL-C Levels for Patients |
Ji-Wung Ryu |
Apr. 17. 25 |
| 6638 |
What are the Real-World Issue to Keep LDL-C Lower for Longer |
Dong-Bin Kim |
Apr. 17. 25 |
| 6637 |
The Prediction of LCX Ostium Narrowing After LMT Crossover Stenting by CCTA |
Masaaki Okutsu |
Apr. 17. 25 |
| 6636 |
CT-Based SYNTAX Score for Comprehensive Assessment of Advanced CAD |
Yoshinobu Onuma |
Apr. 17. 25 |
| 6635 |
Role of Repufusion and IMR in PPCI and ACS |
Robert Thomas Gerber |
Apr. 17. 25 |
| 6634 |
Angiography-Derived Radial Wall Strain: Plaque Characteristics and Outcomes |
Shengxian Tu |
Apr. 17. 25 |
